BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pinky, Gupta S, Krishnakumar V, Sharma Y, Dinda AK, Mohanty S. Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19. Stem Cell Rev Rep 2021;17:33-43. [PMID: 32661867 DOI: 10.1007/s12015-020-10002-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 33] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Xia X, Yuan P, Liu Y, Wang Y, Cao W, Zheng JC. Emerging roles of extracellular vesicles in COVID-19, a double-edged sword? Immunology 2021;163:416-30. [PMID: 33742451 DOI: 10.1111/imm.13329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 O'Rourke RW, Lumeng CN. Pathways to Severe COVID-19 for People with Obesity. Obesity (Silver Spring) 2021;29:645-53. [PMID: 33270351 DOI: 10.1002/oby.23099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
3 Karn V, Ahmed S, Tsai LW, Dubey R, Ojha S, Singh HN, Kumar M, Gupta PK, Sadhu S, Jha NK, Kumar A, Pandit S, Kumar S. Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects. Biomedicines 2021;9:1373. [PMID: 34680490 DOI: 10.3390/biomedicines9101373] [Reference Citation Analysis]
4 Melchor-Martínez EM, Torres Castillo NE, Macias-Garbett R, Lucero-Saucedo SL, Parra-Saldívar R, Sosa-Hernández JE. Modern World Applications for Nano-Bio Materials: Tissue Engineering and COVID-19. Front Bioeng Biotechnol 2021;9:597958. [PMID: 34055754 DOI: 10.3389/fbioe.2021.597958] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mazini L, Ezzoubi M, Malka G. Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19. Stem Cell Res Ther 2021;12:1. [PMID: 33397467 DOI: 10.1186/s13287-020-02006-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
6 Krishnan A, Muthusamy S, Fernandez FB, Kasoju N. Mesenchymal Stem Cell-Derived Extracellular Vesicles in the Management of COVID19-Associated Lung Injury: A Review on Publications, Clinical Trials and Patent Landscape. Tissue Eng Regen Med 2022. [PMID: 35384633 DOI: 10.1007/s13770-022-00441-9] [Reference Citation Analysis]
7 Jayaramayya K, Mahalaxmi I, Subramaniam MD, Raj N, Dayem AA, Lim KM, Kim SJ, An JY, Lee Y, Choi Y, Raj A, Cho SG, Vellingiri B. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment. BMB Rep 2020;53:400-12. [PMID: 32731913 [PMID: 32731913 DOI: 10.5483/bmbrep.2020.53.8.121] [Cited by in Crossref: 11] [Article Influence: 5.5] [Reference Citation Analysis]
8 Park DJ, Park JE, Lee SH, Eliceiri BP, Choi JS, Kim SK, Seo YJ. Protective effect of MSC-derived exosomes against cisplatin-induced apoptosis via heat shock protein 70 in auditory explant model. Nanomedicine 2021;:102447. [PMID: 34314868 DOI: 10.1016/j.nano.2021.102447] [Reference Citation Analysis]
9 Chen L, Qu J, Kalyani FS, Zhang Q, Fan L, Fang Y, Li Y, Xiang C. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-021-04096-y] [Reference Citation Analysis]
10 Liu S, Wu X, Sutapa C, Lyon C, Ning B, jiang L, Fan J, Hu TY. Extracellular vesicles: Emerging tools as therapeutic agent carriers. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.05.002] [Reference Citation Analysis]
11 Yu B, Ikhlas S, Ruan C, Zhong X, Cai D. Innate and Adaptive Immunity of Murine Neural Stem Cell-Derived piRNA Exosomes/Microvesicles against Pseudotyped SARS-CoV-2 and HIV-Based Lentivirus. iScience 2020;23:101806. [PMID: 33205008 DOI: 10.1016/j.isci.2020.101806] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Sharma S, Jeyaraman M, Muthu S, Anudeep TC, Jeyaraman N, Shringeri AS, Kumar V, Somasundaram R, Jain R, Jha SK. A Step Toward Optimizing Regenerative Medicine Principle to Combat COVID-19. Ann Natl Acad Med Sci 2021;57:202-13. [DOI: 10.1055/s-0041-1731597] [Reference Citation Analysis]
13 Ardalan M, Chodari L, Zununi Vahed S, Hosseiniyan Khatibi SM, Eftekhari A, Davaran S, Cucchiarini M, Roshangar L, Ahmadian E. Stem cell-derived biofactors fight against coronavirus infection. World J Stem Cells 2021; 13(12): 1813-1825 [DOI: 10.4252/wjsc.v13.i12.1813] [Reference Citation Analysis]
14 Elashiry M, Elsayed R, Elashiry MM, Rashid MH, Ara R, Arbab AS, Elawady AR, Hamrick M, Liu Y, Zhi W, Lucas R, Vazquez J, Cutler CW. Proteomic Characterization, Biodistribution, and Functional Studies of Immune-Therapeutic Exosomes: Implications for Inflammatory Lung Diseases. Front Immunol 2021;12:636222. [PMID: 33841418 DOI: 10.3389/fimmu.2021.636222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Lai C, Lee C, Vu C, Vu V, Tsai Y, Chen W, Cheng C. Paper-Based Devices for Capturing Exosomes and Exosomal Nucleic Acids From Biological Samples. Front Bioeng Biotechnol 2022;10:836082. [DOI: 10.3389/fbioe.2022.836082] [Reference Citation Analysis]
16 Rafiee Z, Nejaddehbashi F, Nasrolahi A, Khademi Moghadam F. Stem cell-based and mesenchymal stem cell derivatives for coronavirus treatment. Biotechnol Appl Biochem 2021. [PMID: 34555225 DOI: 10.1002/bab.2259] [Reference Citation Analysis]
17 Elashiry M, Morandini AC, Cornelius Timothius CJ, Ghaly M, Cutler CW. Selective Antimicrobial Therapies for Periodontitis: Win the "Battle and the War". Int J Mol Sci 2021;22:6459. [PMID: 34208697 DOI: 10.3390/ijms22126459] [Reference Citation Analysis]
18 Pironti G, Andersson DC, Lund LH. Mechanistic and Therapeutic Implications of Extracellular Vesicles as a Potential Link Between Covid-19 and Cardiovascular Disease Manifestations. Front Cell Dev Biol 2021;9:640723. [PMID: 33644077 DOI: 10.3389/fcell.2021.640723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Yousefi Dehbidi M, Goodarzi N, Azhdari MH, Doroudian M. Mesenchymal stem cells and their derived exosomes to combat Covid-19. Rev Med Virol 2021;:e2281. [PMID: 34363275 DOI: 10.1002/rmv.2281] [Reference Citation Analysis]
20 Elashiry M, Elsayed R, Cutler CW. Exogenous and Endogenous Dendritic Cell-Derived Exosomes: Lessons Learned for Immunotherapy and Disease Pathogenesis. Cells 2021;11:115. [PMID: 35011677 DOI: 10.3390/cells11010115] [Reference Citation Analysis]
21 Nazerian Y, Vakili K, Ebrahimi A, Niknejad H. Developing Cytokine Storm-Sensitive Therapeutic Strategy in COVID-19 Using 8P9R Chimeric Peptide and Soluble ACE2. Front Cell Dev Biol 2021;9:717587. [PMID: 34540833 DOI: 10.3389/fcell.2021.717587] [Reference Citation Analysis]
22 Patil M, Singh S, Henderson J, Krishnamurthy P. Mechanisms of COVID-19-induced cardiovascular disease: Is sepsis or exosome the missing link? J Cell Physiol 2021;236:3366-82. [PMID: 33078408 DOI: 10.1002/jcp.30109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
23 Singh M, Agarwal S, Agarwal V, Mall S, Pancham P, Mani S. Current theranostic approaches for metastatic cancers through hypoxia-induced exosomal packaged cargo. Life Sci 2021;286:120017. [PMID: 34619169 DOI: 10.1016/j.lfs.2021.120017] [Reference Citation Analysis]
24 Ranjbar S, Fatahi Y, Atyabi F. The quest for a better fight: How can nanomaterials address the current therapeutic and diagnostic obstacles in the fight against COVID-19? J Drug Deliv Sci Technol 2021;:102899. [PMID: 34630635 DOI: 10.1016/j.jddst.2021.102899] [Reference Citation Analysis]
25 Olga J, Regina H, Alena S, David P, Michaela L, Malinska HA, Jan M. Conventional and Nonconventional Sources of Exosomes–Isolation Methods and Influence on Their Downstream Biomedical Application. Front Mol Biosci 2022;9:846650. [DOI: 10.3389/fmolb.2022.846650] [Reference Citation Analysis]
26 Zoulikha M, Huang F, Wu Z, He W. COVID-19 inflammation and implications in drug delivery. J Control Release 2022;346:260-74. [PMID: 35469984 DOI: 10.1016/j.jconrel.2022.04.027] [Reference Citation Analysis]
27 Pereira-Silva M, Chauhan G, Shin MD, Hoskins C, Madou MJ, Martinez-Chapa SO, Steinmetz NF, Veiga F, Paiva-Santos AC. Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination. Expert Opin Drug Deliv 2021;:1-20. [PMID: 33944644 DOI: 10.1080/17425247.2021.1922387] [Reference Citation Analysis]
28 Racchetti G, Meldolesi J. Extracellular Vesicles of Mesenchymal Stem Cells: Therapeutic Properties Discovered with Extraordinary Success. Biomedicines 2021;9:667. [PMID: 34200818 DOI: 10.3390/biomedicines9060667] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Lobo-Galo N, Gálvez-Ruíz JC, Balderrama-Carmona AP, Silva-Beltrán NP, Ruiz-Bustos E. Recent biotechnological advances as potential intervention strategies against COVID-19. 3 Biotech 2021;11:41. [PMID: 33457170 DOI: 10.1007/s13205-020-02619-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Rezakhani L, Kelishadrokhi AF, Soleimanizadeh A, Rahmati S. Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises. Chem Phys Lipids 2021;234:105009. [PMID: 33189639 DOI: 10.1016/j.chemphyslip.2020.105009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
31 Kiaie N, Ghanavati SPM, Miremadi SS, Hadipour A, Aghdam RM. Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Therapy, Preclinical and Clinical Evidence. Int J Stem Cells 2021;14:252-61. [PMID: 34158414 DOI: 10.15283/ijsc20182] [Reference Citation Analysis]
32 Ipinmoroti AO, Matthews QL. Extracellular Vesicles: Roles in Human Viral Infections, Immune-Diagnostic, and Therapeutic Applications. Pathogens 2020;9:E1056. [PMID: 33348699 DOI: 10.3390/pathogens9121056] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
33 Rasmi Y, Saloua KS, Nemati M, Choi JR. Recent Progress in Nanotechnology for COVID-19 Prevention, Diagnostics and Treatment. Nanomaterials (Basel) 2021;11:1788. [PMID: 34361174 DOI: 10.3390/nano11071788] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Fernández-Francos S, Eiro N, González-Galiano N, Vizoso FJ. Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives. Int J Mol Sci 2021;22:7850. [PMID: 34360616 DOI: 10.3390/ijms22157850] [Reference Citation Analysis]
35 Yang Z, Li Y, Wang Z. Recent Advances in the Application of Mesenchymal Stem Cell-Derived Exosomes for Cardiovascular and Neurodegenerative Disease Therapies. Pharmaceutics 2022;14:618. [DOI: 10.3390/pharmaceutics14030618] [Reference Citation Analysis]
36 Fröhlich E. Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases-Intravenous Administration versus Inhalation. Pharmaceutics 2021;13:232. [PMID: 33562240 DOI: 10.3390/pharmaceutics13020232] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
37 Witika BA, Makoni PA, Mweetwa LL, Ntemi PV, Chikukwa MTR, Matafwali SK, Mwila C, Mudenda S, Katandula J, Walker RB. Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment. Molecules 2020;25:E5952. [PMID: 33339110 DOI: 10.3390/molecules25245952] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
38 Varahachalam SP, Lahooti B, Chamaneh M, Bagchi S, Chhibber T, Morris K, Bolanos JF, Kim NY, Kaushik A. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects. Int J Nanomedicine 2021;16:539-60. [PMID: 33519200 DOI: 10.2147/IJN.S283686] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 13.0] [Reference Citation Analysis]
39 Ebrahimi M, Rad MTS, Zebardast A, Ayyasi M, Goodarzi G, Tehrani SS. The critical role of mesenchymal stromal/stem cell therapy in COVID-19 patients: An updated review. Cell Biochem Funct 2021. [PMID: 34545605 DOI: 10.1002/cbf.3670] [Reference Citation Analysis]
40 Lutz H, Popowski KD, Dinh PC, Cheng K. Advanced Nanobiomedical Approaches to Combat Coronavirus Disease of 2019. Adv Nanobiomed Res 2021;:2000063. [PMID: 33681865 DOI: 10.1002/anbr.202000063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Goharshadi EK, Goharshadi K, Moghayedi M. The use of nanotechnology in the fight against viruses: A critical review. Coordination Chemistry Reviews 2022;464:214559. [DOI: 10.1016/j.ccr.2022.214559] [Reference Citation Analysis]
42 Zani-Ruttenstock E, Antounians L, Khalaj K, Figueira RL, Zani A. The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19. Eur J Pediatr Surg 2021;31:326-34. [PMID: 34161984 DOI: 10.1055/s-0041-1731294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
43 Serrano-Aroca Á, Takayama K, Tuñón-Molina A, Seyran M, Hassan SS, Pal Choudhury P, Uversky VN, Lundstrom K, Adadi P, Palù G, Aljabali AAA, Chauhan G, Kandimalla R, Tambuwala MM, Lal A, Abd El-Aziz TM, Sherchan S, Barh D, Redwan EM, Bazan NG, Mishra YK, Uhal BD, Brufsky A. Carbon-Based Nanomaterials: Promising Antiviral Agents to Combat COVID-19 in the Microbial-Resistant Era. ACS Nano 2021;15:8069-86. [PMID: 33826850 DOI: 10.1021/acsnano.1c00629] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
44 Mitrani MI, Bellio MA, Sagel A, Saylor M, Kapp W, VanOsdol K, Haskell G, Stewart D, Abdullah Z, Santos I, Milberg J, Arango A, Mitrani A, Shapiro GC. Case Report: Administration of Amniotic Fluid-Derived Nanoparticles in Three Severely Ill COVID-19 Patients. Front Med (Lausanne) 2021;8:583842. [PMID: 33816515 DOI: 10.3389/fmed.2021.583842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Mohammed SA, Shaaban EIA. Efficacious nanomedicine track toward combating COVID-19. Nanotechnology Reviews 2022;11:680-98. [DOI: 10.1515/ntrev-2022-0036] [Reference Citation Analysis]